ProQR Therapeutics N.V. PRQR

$ 3.98 0.38%

Annual report 2023
added 11-09-2024

ProQR Therapeutics N.V. Financial Statements 2011-2024 | PRQR

Annual Financial Statements ProQR Therapeutics N.V.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	68.7 M	188 M	291 M	454 M	85 M	96.9 M	123 M	223 M	-	-	-
Shares	-	-	64.2 M	41 M	41 M	34.1 M	25.4 M	23.3 M	23.3 M	11.1 M	-	-	-
Historical Prices	2.38	1.55	1.07	4.57	7.09	13.3	3.35	4.05	4.34	18.8	-	-	-
Net Income	-	-	-61.7 M	-46.6 M	-56.5 M	-36.9 M	-43.6 M	-39.1 M	-20.8 M	-12.1 M	-3.25 M	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	313 K	-	-	-
Operating Income	-	-	-57.2 M	-42.4 M	-57.4 M	-36.3 M	-40.5 M	-39.6 M	-27 M	-	-	-	-
Interest Expense	1.2 M	-	3.4 M	2.04 M	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-57.2 M	-42.4 M	-57.4 M	-36.3 M	-40.5 M	-38.5 M	-26.6 M	-16.3 M	-3.19 M	-	-
Operating Expenses	41.4 M	69.5 M	59.6 M	51.8 M	59.4 M	42.1 M	42 M	39.8 M	27 M	16.5 M	-	-	-
General and Administrative Expenses	-	-	17.4 M	13.7 M	12.9 M	12.5 M	10.8 M	9.48 M	6.84 M	6.51 M	786 K	-	-

All numbers in EUR currency

Quarterly Income Statement ProQR Therapeutics N.V.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	71.4 M	71.2 M	68.3 M	66.1 M	50.8 M	50.2 M	50.1 M	50 M	49.9 M	47.4 M	38.9 M	38.9 M	38.9 M	-	33.4 M	31.9 M	-	-	-	24 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-14.4 M	-18.2 M	-15.1 M	-15.8 M	-12.6 M	-13.2 M	-13.2 M	-4.12 M	-16.1 M	-18.6 M	-12.2 M	-11.7 M	-14.2 M	-	-5.99 M	-7.4 M	-	-	-	-11.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	1.23 M	239 K	872 K	243 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-16.9 M	-17.3 M	-14.6 M	-13.2 M	-12.1 M	-11.7 M	-10.9 M	-3.36 M	-16.5 M	-17.4 M	-13.4 M	-11.8 M	-14.7 M	-	-5.92 M	-7.67 M	-	-	-	-10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-16.9 M	-17.3 M	-14.6 M	-13.2 M	-12.1 M	-11.7 M	-10.9 M	-3.36 M	-16.5 M	-17.4 M	-13.4 M	-11.8 M	-14.7 M	-	-5.92 M	-7.67 M	-	-	-	-10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	18.3 M	17.8 M	15.7 M	13.9 M	12.2 M	11.9 M	11.1 M	12 M	16.7 M	17.8 M	14 M	12.4 M	15.2 M	-	8.88 M	8.64 M	-	-	-	10.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	4.91 M	5.32 M	4.59 M	4.12 M	3.34 M	3.51 M	2.81 M	3.45 M	3.92 M	3.92 M	2.9 M	2.88 M	3.19 M	-	2.58 M	2.65 M	-	-	-	2.89 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency